Key facts
- Photocure ASA has signed and completed the acquisition of Vesica Health Inc.
- Vesica Health is a U.S. precision diagnostics company.
- Vesica Health's technology is a urine-based diagnostic.
- The acquisition is expected to enhance Photocure's position in bladder cancer diagnostics.
Photocure ASA, a company specializing in bladder cancer diagnostics, announced on June 4, 2026, that it has successfully completed the acquisition of Vesica Health Inc. Vesica Health is a U.S.-based company focused on precision diagnostics, notably advancing its AssureMDx technology, which is a urine-based diagnostic tool. This strategic move is intended to bolster Photocure's leadership in the field of bladder cancer diagnostics by integrating Vesica Health's capabilities and technology.